Anne Chiang

Dr. Anne Chiang is an Associate Professor of Medicine and Associate Cancer Center Director for Clinical Initiatives at Yale School of Medicine. She specializes in thoracic oncology, focusing on small cell and non-small cell lung cancers. Her research emphasizes clinical trials testing novel therapeutics and immunotherapy combinations. She leads quality improvement initiatives at Smilow Care Centers, achieving ASCO QOPI certification. Dr. Chiang holds a PhD from Harvard and an MD from Cornell, with postdoctoral training at Sloan Kettering.

• Education:
• MD: Cornell University Medical College (1999)
• PhD: Harvard University (1995)
• AB: Princeton University (1987)

Research Interests: Her work combines translational research on metastasis with clinical trials targeting lung cancers. She investigates mechanisms of immunotherapy resistance and promotes patient-reported outcomes in care.

Recent Article Trends: Publications emphasize small cell lung cancer reviews, phase II drug trials (e.g., sacituzumab govitecan), and genomic database integration. Her work bridges basic science and clinical practice to improve treatment efficacy and patient outcomes.

• Awards:
• 2020 ASCO Joseph V. Simone Award (Quality & Safety)
• CDA Award (2007–2010)
• Yale Investigator Award (2005)

Advising/Grants: Leads national trials like TROPiCS-03 and Lung-MAP, focusing on drug efficacy and biomarker validation. Collaborates with industry partners (e.g., AbbVie) on antibody-drug conjugates.

Labs/Teams: Active in the Yale Cancer Center and Smilow Care Centers, contributing to multidisciplinary teams advancing precision oncology and quality care frameworks.